Regentis Biomaterials Ltd. RGNT
1.33 USD +0.06 (+4.72%)
At closeNov 10, 2026, 7:46 PM EST
1.27 -0.06 -4.51%
After hours · Nov 10, 7:46 PM ET
1.20 Day range 1.34
1.16 52-week range 15.50
- YTD
- -80.27%
- 1 year
- -82.27%
- Market cap
- 9.34M
- EPS (ttm)
- -2.57
- YTD return
- -80.27%
- 1-year return
- -82.27%
- Volume
- 201.35K
- Avg volume
- 48.42K
- Open
- 1.32
- Previous close
- 1.27
- Day's range
- 1.20 – 1.34
- 52-week range
- 1.16 – 15.50
5D -0.09 (-6.62%)
Financials — quick view
RGNT Revenue — quarterly 16.78M
RGNT Net income — quarterly -2.24M
RGNT EPS — quarterly -0.55
News
Regentis Biomaterials Strikes Distribution Deal With AMI Medical Technologies To Commercialize GelrinC In Israel 
12 Health Care Stocks Moving In Thursday's Intraday Session - 12 Health Care Stocks Moving In Monday's Pre-Market Session
Regentis Biomaterials Reports Strong Surgeon Interest in GelrinC(R) at 8th ICRS Summit in Portugal 
Regentis Biomaterials to Present at the 2026 ThinkEquity Conference on October 15 in New York City 
12 Health Care Stocks Moving In Monday's Intraday Session 
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Ehud Geller, CEO of Regentis Biomaterials Ltd. 
Regentis Biomaterials H1 EPS $(0.44) Up From $(1.17) YoY 
Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update - 12 Health Care Stocks Moving In Tuesday's After-Market Session
Your note
Sign in to keep a note on RGNT — it syncs with the Stock Master app.